Suppr超能文献

了解艾滋病护理提供者对开具暴露前预防药物(PrEP)处方意图的态度。

Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP.

作者信息

Castel Amanda D, Feaster Daniel J, Tang Wenze, Willis Sarah, Jordan Heather, Villamizar Kira, Kharfen Michael, Kolber Michael A, Rodriguez Allan, Metsch Lisa R

机构信息

*Department of Epidemiology and Biostatistics, The Milken Institute School of Public Health, George Washington University, Washington, DC; †Biostatistics Division, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL; ‡Florida Department of Health, Miami-Dade County, Miami, FL; §District of Columbia Department of Health, HIV/AIDS, Hepatitis, STD, TB Administration, Washington, DC; ‖Department of Medicine, University of Miami Miller School of Medicine, Miami, FL; and ¶Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY.

出版信息

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):520-8. doi: 10.1097/QAI.0000000000000780.

Abstract

INTRODUCTION

Preexposure prophylaxis (PrEP) is a promising approach to reducing HIV incidence. So, garnering the support of HIV providers, who are most familiar with antiretrovirals and likely to encounter patients in HIV serodiscordant relationships, to scale-up PrEP implementation is essential. We sought to determine whether certain subgroups of HIV providers were more likely to intend to prescribe PrEP.

METHODS

Surveys were administered to HIV providers in Miami, Florida and Washington, District of Columbia. Composite scores were developed to measure PrEP knowledge, experience, and likelihood of prescribing. Latent class analysis was used to stratify provider attitudes toward PrEP.

RESULTS

Among 142 HIV providers, 73.2% had cared for more than 20 HIV-infected patients in the previous 3 months; 17% had ever prescribed PrEP. Latent class analysis identified 2 classes of providers (entropy, 0.904); class 1 (n = 95) found PrEP less effective and perceived barriers to prescribing it; class 2 (n = 47) perceived PrEP as moderately effective and perceived fewer barriers to prescribing it. Compared with class 2, class 1 had significantly less experience with PrEP delivery (t(22.7) = 2.88, P = 0.009) and was significantly less likely to intend to prescribe to patients with multiple sex partners (20% vs. 43%, P = 0.04) and those with a drug use history (7% vs. 24%, P = 0.001).

CONCLUSIONS

Although most HIV providers found PrEP to be effective, those considering it less effective had limited knowledge and experience with PrEP and had lesser intentions to prescribe. Provider training regarding whom should receive PrEP and addressing potential barriers to PrEP provision are needed if this HIV prevention method is to be optimized.

摘要

引言

暴露前预防(PrEP)是一种很有前景的降低艾滋病病毒(HIV)感染率的方法。因此,获得最熟悉抗逆转录病毒药物且可能接触到处于HIV血清学不一致关系患者的HIV治疗提供者的支持,对于扩大PrEP的实施至关重要。我们试图确定HIV治疗提供者的某些亚组是否更有可能打算开具PrEP处方。

方法

对佛罗里达州迈阿密市和哥伦比亚特区华盛顿的HIV治疗提供者进行了调查。制定了综合评分来衡量PrEP知识、经验和开具处方的可能性。使用潜在类别分析对提供者对PrEP的态度进行分层。

结果

在142名HIV治疗提供者中,73.2%在过去3个月中照顾过20多名HIV感染患者;17%曾开具过PrEP处方。潜在类别分析确定了两类提供者(熵值为0.904);第1类(n = 95)认为PrEP效果较差且察觉到开具处方存在障碍;第2类(n = 47)认为PrEP有一定效果且察觉到开具处方的障碍较少。与第2类相比,第1类在提供PrEP方面的经验明显更少(t(22.7) = 2.88,P = 0.009),并且向有多个性伴侣的患者(20%对43%,P = 0.04)和有吸毒史的患者开具处方的可能性明显更低(7%对24%,P = 0.001)。

结论

尽管大多数HIV治疗提供者认为PrEP有效,但那些认为其效果较差的人对PrEP的知识和经验有限,开具处方的意愿也较低。如果要优化这种HIV预防方法,就需要对提供者进行关于哪些人应接受PrEP以及解决PrEP提供潜在障碍方面的培训。

相似文献

1
Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP.
J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):520-8. doi: 10.1097/QAI.0000000000000780.
4
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
AIDS Patient Care STDS. 2020 Mar;34(3):111-123. doi: 10.1089/apc.2019.0189. Epub 2020 Feb 28.
5
Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru.
AIDS Res Hum Retroviruses. 2014 May;30(5):416-24. doi: 10.1089/AID.2013.0212. Epub 2014 Jan 20.
7
Knowledge, Attitudes, and PrEP Prescribing Practices of Health Care Providers in Philadelphia, PA.
J Prim Care Community Health. 2019 Jan-Dec;10:2150132719878526. doi: 10.1177/2150132719878526.
8
Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region.
J Adolesc Health. 2019 May;64(5):581-588. doi: 10.1016/j.jadohealth.2018.10.300. Epub 2018 Dec 19.
9
Adolescent Health Providers' Willingness to Prescribe Pre-Exposure Prophylaxis (PrEP) to Youth at Risk of HIV Infection in the United States.
J Adolesc Health. 2018 Aug;63(2):242-244. doi: 10.1016/j.jadohealth.2018.03.016. Epub 2018 May 26.

引用本文的文献

3
Determinants of Familiarity and Experience with HIV Pre-Exposure Prophylaxis in Primary Care Providers in Ontario, Canada.
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251315566. doi: 10.1177/21501319251315566.
6
Knowledge and attitudes of HIV pre-exposure prophylaxis among nurses in South Africa.
Afr J Prim Health Care Fam Med. 2023 Sep 19;15(1):e1-e6. doi: 10.4102/phcfm.v15i1.4086.
8
Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City.
Womens Health Issues. 2023 Sep-Oct;33(5):541-550. doi: 10.1016/j.whi.2023.05.009. Epub 2023 Jul 20.
10
HIV-serodifferent couples' perspectives and practices regarding HIV prevention strategies: A mixed methods study.
PLOS Glob Public Health. 2022 Aug 17;2(8):e0000620. doi: 10.1371/journal.pgph.0000620. eCollection 2022.

本文引用的文献

1
Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future.
Infect Dis Clin North Am. 2014 Dec;28(4):563-83. doi: 10.1016/j.idc.2014.08.001. Epub 2014 Nov 20.
3
HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.
J Infect Dis. 2014 Oct 15;210(8):1217-27. doi: 10.1093/infdis/jiu233. Epub 2014 Apr 16.
4
Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru.
AIDS Res Hum Retroviruses. 2014 May;30(5):416-24. doi: 10.1089/AID.2013.0212. Epub 2014 Jan 20.
6
HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.
J Acquir Immune Defic Syndr. 2013 Nov 1;64 Suppl 1(0 1):S68-79. doi: 10.1097/QAI.0b013e3182a901a2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验